Allyx Therapeutics, Inc. funding
Allyx Therapeutics, Inc., a biotechnology company based in New Haven, CT, filed a Form D with the SEC on May 11, 2026 and reported $26.4M raised of a $30M offering. It filed 2 new offerings in this period, totaling $29.8M.
Amount raised$26.4M
Offering size$30M
Filed with the SECMay 11, 2026
First saleMay 4, 2026
IndustryBiotechnology
SecuritiesEquity, Options or warrants, Security to be acquired on exercise
LocationNew Haven, CT
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far32
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed May 11
All filings
| Filed | Raised | Offering | Securities |
|---|---|---|---|
| May 11, 2026 | $26.4M | $30M | Equity, Options or warrants, Security to be acquired on exercise |
| March 3, 2026 | $3.3M | $4M | Options or warrants, Other |